Your browser doesn't support javascript.
loading
THN 102 for Excessive Daytime Sleepiness Associated with Parkinson's Disease: A Phase 2a Trial.
Corvol, Jean-Christophe; Azulay, Jean-Philippe; Bosse, Björn; Dauvilliers, Yves; Defebvre, Luc; Klostermann, Fabian; Kovacs, Norbert; Maltête, David; Ondo, William G; Pahwa, Rajesh; Rein, Werner; Thobois, Stéphane; Valis, Martin; Videnovic, Aleksandar; Rascol, Olivier.
Afiliación
  • Corvol JC; Department of Neurology, Centre d'Investigation Clinique Neurosciences, NS-PARK/FCRIN Network, Sorbonne Université, Assistance Publique Hôpitaux de Paris, Paris Brain Institute-ICM, INSERM, CNRS, Hôpital Pitié-Salpêtrière, Paris, France.
  • Azulay JP; Department of Neurology and Movement Disorders, La Timone Hospital, Assistance Publique-Hôpitaux de Marseille, NS-PARK/FCRIN Network, Marseille, France.
  • Bosse B; Scope International, Mannheim, Germany.
  • Dauvilliers Y; Sleep-Wake Disorders Center, Department of Neurology, Gui-de-Chauliac Hospital, CHU Montpellier, University of Montpellier, Montpellier, France.
  • Defebvre L; Department of Neurology and Movement Disorders, Lille University Medical Center, NS-PARK/FCRIN Network, Lille, France.
  • Klostermann F; Department of Neurology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.
  • Kovacs N; Department of Neurology, Medical School University of Pecs, Pecs, Hungary.
  • Maltête D; Department of Neurology, Rouen University Hospital and University of Rouen, NS-PARK/FCRIN Network, Rouen, France.
  • Ondo WG; Movement Disorders-Methodist Neurological Institute, Weill Cornel Medical School, Houston, Texas, USA.
  • Pahwa R; Movement Disorders Division, University of Kansas Medical Center, Kansas City, Kansas, USA.
  • Rein W; Theranexus SA, Lyon, France.
  • Thobois S; Department of Neurology C, Pierre-Wertheimer Neurological Hospital, Hospices Civils de Lyon, NS-PARK/FCRIN Network, Univ Lyon, CNRS, Institut des Sciences Cognitives Marc Jeannerod, Bron, France.
  • Valis M; Department of Neurology, Charles University, Faculty of Medicine and University Hospital, Hradec Kralove, Czechia.
  • Videnovic A; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Rascol O; Departments of Neurology and Clinical Pharmacology, Centre of Clinique Investigations, NS-Park/FCRIN Network, Centre of Excellence for Neurodegenerative Disorders (COEN) of Toulouse, CHU de Toulouse, Toulouse 3 University, NS-PARK/FCRIN Network, Toulouse, France.
Mov Disord ; 37(2): 410-415, 2022 02.
Article en En | MEDLINE | ID: mdl-34709684
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Flecainida / Modafinilo / Trastornos de Somnolencia Excesiva Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Mov Disord Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Flecainida / Modafinilo / Trastornos de Somnolencia Excesiva Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Mov Disord Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Francia